The Anti-Snoring Devices Market focuses on products designed to reduce or eliminate snoring by improving airflow during sleep. These devices address issues such as nasal congestion, airway obstruction, or soft palate vibration—common causes of snoring—and are used both for lifestyle improvement and to manage mild cases of sleep apnea. The market includes a variety of solutions such as mandibular advancement devices (MADs), tongue stabilizing devices, nasal dilators, chin straps, and smart anti-snoring wearables.
According to Fortune Business Insights, the anti-snoring devices market share was valued at USD 1.07 billion in 2024 and is projected to grow from USD 1.15 billion in 2025 to USD 1.94 billion by 2032, exhibiting a CAGR of 7.7% during the forecast period. North America dominated the market, accounting for a 40.18% share in 2024.
The anti-snoring devices market report provides a detailed analysis of industry dynamics, covering revenue forecasts, regional trends, device types, and distribution channels from 2019 to 2032. It evaluates growth drivers, restraints, and opportunities shaping the market’s competitive environment while highlighting recent product innovations and regulatory developments.
SomnoMed (Australia)
ResMed (U.S.)
Glidewell (U.S.)
PANTHERA DENTAL (Canada)
Frantz Design Inc. (U.S.)
BlueSleep (U.S.)
ProSomnus Sleep Technologies (U.S.)
Fisher & Paykel Healthcare Limited (New Zealand)
Apnea Sciences (U.S.)
DynaFlex (U.S.)